世界の無細胞胎児DNA検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Cell-Free Fetal DNA Testing Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1212
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、無細胞胎児DNA検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（異常染色体数検出、性別検査、父性遺伝障害検出、親子鑑定、その他）、用途別市場規模（病院、クリニックセンター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・無細胞胎児DNA検査の市場動向
・企業の競争状況、市場シェア
・無細胞胎児DNA検査の種類別市場規模（異常染色体数検出、性別検査、父性遺伝障害検出、親子鑑定、その他）
・無細胞胎児DNA検査の用途別市場規模（病院、クリニックセンター）
・無細胞胎児DNA検査の北米市場規模2016-2027（アメリカ、カナダ）
・無細胞胎児DNA検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・無細胞胎児DNA検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・無細胞胎児DNA検査の中南米市場規模2016-2027（メキシコ、ブラジル）
・無細胞胎児DNA検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Sequenom Laboratories、Illumina, Inc.、Ariosa Diagnostics、Arup Laboratories、The Fetal Medicine Centre、Apollo Path labs）
・結論

Market Analysis and Insights: Global Cell-Free Fetal DNA Testing Market
The global Cell-Free Fetal DNA Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cell-Free Fetal DNA Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cell-Free Fetal DNA Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cell-Free Fetal DNA Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cell-Free Fetal DNA Testing market.

Global Cell-Free Fetal DNA Testing Scope and Market Size
Cell-Free Fetal DNA Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cell-Free Fetal DNA Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Abnormal Chromosome Number Detection
Gender Testing
Paternally Inherited Disorder Detection
Paternity testing
Others

Segment by Application
Hospital
Clinic Center

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sequenom Laboratories
Illumina, Inc.
Ariosa Diagnostics
Arup Laboratories
The Fetal Medicine Centre
Apollo Path labs

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell-Free Fetal DNA Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Abnormal Chromosome Number Detection
1.2.3 Gender Testing
1.2.4 Paternally Inherited Disorder Detection
1.2.5 Paternity testing
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cell-Free Fetal DNA Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic Center
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cell-Free Fetal DNA Testing Market Perspective (2016-2027)
2.2 Cell-Free Fetal DNA Testing Growth Trends by Regions
2.2.1 Cell-Free Fetal DNA Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cell-Free Fetal DNA Testing Historic Market Share by Regions (2016-2021)
2.2.3 Cell-Free Fetal DNA Testing Forecasted Market Size by Regions (2022-2027)
2.3 Cell-Free Fetal DNA Testing Industry Dynamic
2.3.1 Cell-Free Fetal DNA Testing Market Trends
2.3.2 Cell-Free Fetal DNA Testing Market Drivers
2.3.3 Cell-Free Fetal DNA Testing Market Challenges
2.3.4 Cell-Free Fetal DNA Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cell-Free Fetal DNA Testing Players by Revenue
3.1.1 Global Top Cell-Free Fetal DNA Testing Players by Revenue (2016-2021)
3.1.2 Global Cell-Free Fetal DNA Testing Revenue Market Share by Players (2016-2021)
3.2 Global Cell-Free Fetal DNA Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cell-Free Fetal DNA Testing Revenue
3.4 Global Cell-Free Fetal DNA Testing Market Concentration Ratio
3.4.1 Global Cell-Free Fetal DNA Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell-Free Fetal DNA Testing Revenue in 2020
3.5 Cell-Free Fetal DNA Testing Key Players Head office and Area Served
3.6 Key Players Cell-Free Fetal DNA Testing Product Solution and Service
3.7 Date of Enter into Cell-Free Fetal DNA Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cell-Free Fetal DNA Testing Breakdown Data by Type
4.1 Global Cell-Free Fetal DNA Testing Historic Market Size by Type (2016-2021)
4.2 Global Cell-Free Fetal DNA Testing Forecasted Market Size by Type (2022-2027)

5 Cell-Free Fetal DNA Testing Breakdown Data by Application
5.1 Global Cell-Free Fetal DNA Testing Historic Market Size by Application (2016-2021)
5.2 Global Cell-Free Fetal DNA Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cell-Free Fetal DNA Testing Market Size (2016-2027)
6.2 North America Cell-Free Fetal DNA Testing Market Size by Type
6.2.1 North America Cell-Free Fetal DNA Testing Market Size by Type (2016-2021)
6.2.2 North America Cell-Free Fetal DNA Testing Market Size by Type (2022-2027)
6.2.3 North America Cell-Free Fetal DNA Testing Market Size by Type (2016-2027)
6.3 North America Cell-Free Fetal DNA Testing Market Size by Application
6.3.1 North America Cell-Free Fetal DNA Testing Market Size by Application (2016-2021)
6.3.2 North America Cell-Free Fetal DNA Testing Market Size by Application (2022-2027)
6.3.3 North America Cell-Free Fetal DNA Testing Market Size by Application (2016-2027)
6.4 North America Cell-Free Fetal DNA Testing Market Size by Country
6.4.1 North America Cell-Free Fetal DNA Testing Market Size by Country (2016-2021)
6.4.2 North America Cell-Free Fetal DNA Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Cell-Free Fetal DNA Testing Market Size (2016-2027)
7.2 Europe Cell-Free Fetal DNA Testing Market Size by Type
7.2.1 Europe Cell-Free Fetal DNA Testing Market Size by Type (2016-2021)
7.2.2 Europe Cell-Free Fetal DNA Testing Market Size by Type (2022-2027)
7.2.3 Europe Cell-Free Fetal DNA Testing Market Size by Type (2016-2027)
7.3 Europe Cell-Free Fetal DNA Testing Market Size by Application
7.3.1 Europe Cell-Free Fetal DNA Testing Market Size by Application (2016-2021)
7.3.2 Europe Cell-Free Fetal DNA Testing Market Size by Application (2022-2027)
7.3.3 Europe Cell-Free Fetal DNA Testing Market Size by Application (2016-2027)
7.4 Europe Cell-Free Fetal DNA Testing Market Size by Country
7.4.1 Europe Cell-Free Fetal DNA Testing Market Size by Country (2016-2021)
7.4.2 Europe Cell-Free Fetal DNA Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cell-Free Fetal DNA Testing Market Size (2016-2027)
8.2 Asia-Pacific Cell-Free Fetal DNA Testing Market Size by Type
8.2.1 Asia-Pacific Cell-Free Fetal DNA Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cell-Free Fetal DNA Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cell-Free Fetal DNA Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Cell-Free Fetal DNA Testing Market Size by Application
8.3.1 Asia-Pacific Cell-Free Fetal DNA Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cell-Free Fetal DNA Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cell-Free Fetal DNA Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Cell-Free Fetal DNA Testing Market Size by Region
8.4.1 Asia-Pacific Cell-Free Fetal DNA Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cell-Free Fetal DNA Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cell-Free Fetal DNA Testing Market Size (2016-2027)
9.2 Latin America Cell-Free Fetal DNA Testing Market Size by Type
9.2.1 Latin America Cell-Free Fetal DNA Testing Market Size by Type (2016-2021)
9.2.2 Latin America Cell-Free Fetal DNA Testing Market Size by Type (2022-2027)
9.2.3 Latin America Cell-Free Fetal DNA Testing Market Size by Type (2016-2027)
9.3 Latin America Cell-Free Fetal DNA Testing Market Size by Application
9.3.1 Latin America Cell-Free Fetal DNA Testing Market Size by Application (2016-2021)
9.3.2 Latin America Cell-Free Fetal DNA Testing Market Size by Application (2022-2027)
9.3.3 Latin America Cell-Free Fetal DNA Testing Market Size by Application (2016-2027)
9.4 Latin America Cell-Free Fetal DNA Testing Market Size by Country
9.4.1 Latin America Cell-Free Fetal DNA Testing Market Size by Country (2016-2021)
9.4.2 Latin America Cell-Free Fetal DNA Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cell-Free Fetal DNA Testing Market Size (2016-2027)
10.2 Middle East & Africa Cell-Free Fetal DNA Testing Market Size by Type
10.2.1 Middle East & Africa Cell-Free Fetal DNA Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cell-Free Fetal DNA Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cell-Free Fetal DNA Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Cell-Free Fetal DNA Testing Market Size by Application
10.3.1 Middle East & Africa Cell-Free Fetal DNA Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cell-Free Fetal DNA Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cell-Free Fetal DNA Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Cell-Free Fetal DNA Testing Market Size by Country
10.4.1 Middle East & Africa Cell-Free Fetal DNA Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cell-Free Fetal DNA Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sequenom Laboratories
11.1.1 Sequenom Laboratories Company Details
11.1.2 Sequenom Laboratories Business Overview
11.1.3 Sequenom Laboratories Cell-Free Fetal DNA Testing Introduction
11.1.4 Sequenom Laboratories Revenue in Cell-Free Fetal DNA Testing Business (2016-2021)
11.1.5 Sequenom Laboratories Recent Development
11.2 Illumina, Inc.
11.2.1 Illumina, Inc. Company Details
11.2.2 Illumina, Inc. Business Overview
11.2.3 Illumina, Inc. Cell-Free Fetal DNA Testing Introduction
11.2.4 Illumina, Inc. Revenue in Cell-Free Fetal DNA Testing Business (2016-2021)
11.2.5 Illumina, Inc. Recent Development
11.3 Ariosa Diagnostics
11.3.1 Ariosa Diagnostics Company Details
11.3.2 Ariosa Diagnostics Business Overview
11.3.3 Ariosa Diagnostics Cell-Free Fetal DNA Testing Introduction
11.3.4 Ariosa Diagnostics Revenue in Cell-Free Fetal DNA Testing Business (2016-2021)
11.3.5 Ariosa Diagnostics Recent Development
11.4 Arup Laboratories
11.4.1 Arup Laboratories Company Details
11.4.2 Arup Laboratories Business Overview
11.4.3 Arup Laboratories Cell-Free Fetal DNA Testing Introduction
11.4.4 Arup Laboratories Revenue in Cell-Free Fetal DNA Testing Business (2016-2021)
11.4.5 Arup Laboratories Recent Development
11.5 The Fetal Medicine Centre
11.5.1 The Fetal Medicine Centre Company Details
11.5.2 The Fetal Medicine Centre Business Overview
11.5.3 The Fetal Medicine Centre Cell-Free Fetal DNA Testing Introduction
11.5.4 The Fetal Medicine Centre Revenue in Cell-Free Fetal DNA Testing Business (2016-2021)
11.5.5 The Fetal Medicine Centre Recent Development
11.6 Apollo Path labs
11.6.1 Apollo Path labs Company Details
11.6.2 Apollo Path labs Business Overview
11.6.3 Apollo Path labs Cell-Free Fetal DNA Testing Introduction
11.6.4 Apollo Path labs Revenue in Cell-Free Fetal DNA Testing Business (2016-2021)
11.6.5 Apollo Path labs Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cell-Free Fetal DNA Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Abnormal Chromosome Number Detection
Table 3. Key Players of Gender Testing
Table 4. Key Players of Paternally Inherited Disorder Detection
Table 5. Key Players of Paternity testing
Table 6. Key Players of Others
Table 7. Global Cell-Free Fetal DNA Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cell-Free Fetal DNA Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Cell-Free Fetal DNA Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Cell-Free Fetal DNA Testing Market Share by Regions (2016-2021)
Table 11. Global Cell-Free Fetal DNA Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Cell-Free Fetal DNA Testing Market Share by Regions (2022-2027)
Table 13. Cell-Free Fetal DNA Testing Market Trends
Table 14. Cell-Free Fetal DNA Testing Market Drivers
Table 15. Cell-Free Fetal DNA Testing Market Challenges
Table 16. Cell-Free Fetal DNA Testing Market Restraints
Table 17. Global Cell-Free Fetal DNA Testing Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Cell-Free Fetal DNA Testing Market Share by Players (2016-2021)
Table 19. Global Top Cell-Free Fetal DNA Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell-Free Fetal DNA Testing as of 2020)
Table 20. Ranking of Global Top Cell-Free Fetal DNA Testing Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Cell-Free Fetal DNA Testing Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cell-Free Fetal DNA Testing Product Solution and Service
Table 24. Date of Enter into Cell-Free Fetal DNA Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cell-Free Fetal DNA Testing Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Cell-Free Fetal DNA Testing Revenue Market Share by Type (2016-2021)
Table 28. Global Cell-Free Fetal DNA Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Cell-Free Fetal DNA Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Cell-Free Fetal DNA Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Cell-Free Fetal DNA Testing Revenue Market Share by Application (2016-2021)
Table 32. Global Cell-Free Fetal DNA Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Cell-Free Fetal DNA Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Cell-Free Fetal DNA Testing Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Cell-Free Fetal DNA Testing Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Cell-Free Fetal DNA Testing Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Cell-Free Fetal DNA Testing Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Cell-Free Fetal DNA Testing Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Cell-Free Fetal DNA Testing Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Cell-Free Fetal DNA Testing Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Cell-Free Fetal DNA Testing Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Cell-Free Fetal DNA Testing Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Cell-Free Fetal DNA Testing Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Cell-Free Fetal DNA Testing Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Cell-Free Fetal DNA Testing Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cell-Free Fetal DNA Testing Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cell-Free Fetal DNA Testing Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cell-Free Fetal DNA Testing Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Cell-Free Fetal DNA Testing Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Cell-Free Fetal DNA Testing Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Cell-Free Fetal DNA Testing Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Cell-Free Fetal DNA Testing Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Cell-Free Fetal DNA Testing Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Cell-Free Fetal DNA Testing Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Cell-Free Fetal DNA Testing Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Cell-Free Fetal DNA Testing Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Cell-Free Fetal DNA Testing Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cell-Free Fetal DNA Testing Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cell-Free Fetal DNA Testing Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cell-Free Fetal DNA Testing Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Cell-Free Fetal DNA Testing Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Cell-Free Fetal DNA Testing Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Cell-Free Fetal DNA Testing Market Size by Country (2022-2027) & (US$ Million)
Table 64. Sequenom Laboratories Company Details
Table 65. Sequenom Laboratories Business Overview
Table 66. Sequenom Laboratories Cell-Free Fetal DNA Testing Product
Table 67. Sequenom Laboratories Revenue in Cell-Free Fetal DNA Testing Business (2016-2021) & (US$ Million)
Table 68. Sequenom Laboratories Recent Development
Table 69. Illumina, Inc. Company Details
Table 70. Illumina, Inc. Business Overview
Table 71. Illumina, Inc. Cell-Free Fetal DNA Testing Product
Table 72. Illumina, Inc. Revenue in Cell-Free Fetal DNA Testing Business (2016-2021) & (US$ Million)
Table 73. Illumina, Inc. Recent Development
Table 74. Ariosa Diagnostics Company Details
Table 75. Ariosa Diagnostics Business Overview
Table 76. Ariosa Diagnostics Cell-Free Fetal DNA Testing Product
Table 77. Ariosa Diagnostics Revenue in Cell-Free Fetal DNA Testing Business (2016-2021) & (US$ Million)
Table 78. Ariosa Diagnostics Recent Development
Table 79. Arup Laboratories Company Details
Table 80. Arup Laboratories Business Overview
Table 81. Arup Laboratories Cell-Free Fetal DNA Testing Product
Table 82. Arup Laboratories Revenue in Cell-Free Fetal DNA Testing Business (2016-2021) & (US$ Million)
Table 83. Arup Laboratories Recent Development
Table 84. The Fetal Medicine Centre Company Details
Table 85. The Fetal Medicine Centre Business Overview
Table 86. The Fetal Medicine Centre Cell-Free Fetal DNA Testing Product
Table 87. The Fetal Medicine Centre Revenue in Cell-Free Fetal DNA Testing Business (2016-2021) & (US$ Million)
Table 88. The Fetal Medicine Centre Recent Development
Table 89. Apollo Path labs Company Details
Table 90. Apollo Path labs Business Overview
Table 91. Apollo Path labs Cell-Free Fetal DNA Testing Product
Table 92. Apollo Path labs Revenue in Cell-Free Fetal DNA Testing Business (2016-2021) & (US$ Million)
Table 93. Apollo Path labs Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell-Free Fetal DNA Testing Market Share by Type: 2020 VS 2027
Figure 2. Abnormal Chromosome Number Detection Features
Figure 3. Gender Testing Features
Figure 4. Paternally Inherited Disorder Detection Features
Figure 5. Paternity testing Features
Figure 6. Others Features
Figure 7. Global Cell-Free Fetal DNA Testing Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinic Center Case Studies
Figure 10. Cell-Free Fetal DNA Testing Report Years Considered
Figure 11. Global Cell-Free Fetal DNA Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Cell-Free Fetal DNA Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Cell-Free Fetal DNA Testing Market Share by Regions: 2020 VS 2027
Figure 14. Global Cell-Free Fetal DNA Testing Market Share by Regions (2022-2027)
Figure 15. Global Cell-Free Fetal DNA Testing Market Share by Players in 2020
Figure 16. Global Top Cell-Free Fetal DNA Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell-Free Fetal DNA Testing as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Cell-Free Fetal DNA Testing Revenue in 2020
Figure 18. Global Cell-Free Fetal DNA Testing Revenue Market Share by Type (2016-2021)
Figure 19. Global Cell-Free Fetal DNA Testing Revenue Market Share by Type (2022-2027)
Figure 20. North America Cell-Free Fetal DNA Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Cell-Free Fetal DNA Testing Market Share by Type (2016-2027)
Figure 22. North America Cell-Free Fetal DNA Testing Market Share by Application (2016-2027)
Figure 23. North America Cell-Free Fetal DNA Testing Market Share by Country (2016-2027)
Figure 24. United States Cell-Free Fetal DNA Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Cell-Free Fetal DNA Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cell-Free Fetal DNA Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cell-Free Fetal DNA Testing Market Share by Type (2016-2027)
Figure 28. Europe Cell-Free Fetal DNA Testing Market Share by Application (2016-2027)
Figure 29. Europe Cell-Free Fetal DNA Testing Market Share by Country (2016-2027)
Figure 30. Germany Cell-Free Fetal DNA Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Cell-Free Fetal DNA Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Cell-Free Fetal DNA Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Cell-Free Fetal DNA Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Cell-Free Fetal DNA Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Cell-Free Fetal DNA Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cell-Free Fetal DNA Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cell-Free Fetal DNA Testing Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Cell-Free Fetal DNA Testing Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Cell-Free Fetal DNA Testing Market Share by Region (2016-2027)
Figure 40. China Cell-Free Fetal DNA Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Cell-Free Fetal DNA Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Cell-Free Fetal DNA Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Cell-Free Fetal DNA Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Cell-Free Fetal DNA Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Cell-Free Fetal DNA Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cell-Free Fetal DNA Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cell-Free Fetal DNA Testing Market Share by Type (2016-2027)
Figure 48. Latin America Cell-Free Fetal DNA Testing Market Share by Application (2016-2027)
Figure 49. Latin America Cell-Free Fetal DNA Testing Market Share by Country (2016-2027)
Figure 50. Mexico Cell-Free Fetal DNA Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Cell-Free Fetal DNA Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cell-Free Fetal DNA Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cell-Free Fetal DNA Testing Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Cell-Free Fetal DNA Testing Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Cell-Free Fetal DNA Testing Market Share by Country (2016-2027)
Figure 56. Turkey Cell-Free Fetal DNA Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Cell-Free Fetal DNA Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Cell-Free Fetal DNA Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Sequenom Laboratories Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2016-2021)
Figure 60. Illumina, Inc. Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2016-2021)
Figure 61. Ariosa Diagnostics Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2016-2021)
Figure 62. Arup Laboratories Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2016-2021)
Figure 63. The Fetal Medicine Centre Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2016-2021)
Figure 64. Apollo Path labs Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Global Cell-Free DNA (cfDNA) Testing Market Size, Status and Forecast 2021-2027
QYR2104Z1210 2021年4月 97Pages
QYResearch社発行の本調査資料では、無細胞DNA（cfDNA）検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ドナー由来無細胞DNA（DdcfDNA）、無細胞腫瘍DNA（CtDNA）、無細胞胎児DNA（NIPT））、用途別市場規模（...

世界の無細胞DNA（cf-DNA）検査市場規模・現状・予測（2021年-2027年）

Global Cell-Free DNA (cf-DNA) Testing Market Size, Status and Forecast 2021-2027
QYR2104Z1211 2021年4月 94Pages
QYResearch社発行の本調査資料では、無細胞DNA（cf-DNA）検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ドナー由来、循環、無細胞）、用途別市場規模（腫瘍、婦人科、移植）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界の細胞ベースラベルフリーモニタリング市場規模・現状・予測（2021年-2027年）

Global Cell-Based Label Free Monitoring Market Size, Status and Forecast 2021-2027
QYR2104Z1209 2021年4月 98Pages
QYResearch社発行の本調査資料では、細胞ベースラベルフリーモニタリングのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（電気化学、光学、圧電）、用途別市場規模（製薬・バイオテクノロジー企業、学術/研究所機関）、主要地域別市場規模（北米、ア...

世界の宿主細胞汚染物質試験市場規模・現状・予測（2021年-2027年）

Global Host Cell Contaminant Testing Market Size, Status and Forecast 2021-2027
QYR2104Z2925 2021年4月 91Pages
QYResearch社発行の本調査資料では、宿主細胞汚染物質試験のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（微生物、哺乳類、その他）、用途別市場規模（研究・開発、臨床用）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、...

世界の胎児モニタリング分析市場規模・現状・予測（2021年-2027年）

Global Fetal Monitoring Analysis Market Size, Status and Forecast 2021-2027
QYR2104Z2344 2021年4月 92Pages
QYResearch社発行の本調査資料では、胎児モニタリング分析のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（機器、消耗品）、用途別市場規模（分娩前、分娩中）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、...

世界の胎児アルコールスペクトラム障害治療市場規模・現状・予測（2021年-2027年）

Global Fetal Alcohol Spectrum Disorder Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2343 2021年4月 96Pages
QYResearch社発行の本調査資料では、胎児アルコールスペクトラム障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗うつ薬、覚醒剤、神経弛緩薬、抗不安薬）、用途別市場規模（病院薬局、小売薬局、ドラッグストア、Eコマース）、主要地域別...

世界の胎児モニタリング市場規模・現状・予測（2021年-2027年）

Global Fetal Monitoring Market Size, Status and Forecast 2021-2027
QYR2104Z2345 2021年4月 90Pages
QYResearch社発行の本調査資料では、胎児モニタリングのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（分娩前胎児モニタリング、分娩中胎児モニタリング）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界の侵襲性胎児モニタリング市場規模・現状・予測（2021年-2027年）

Global Invasive Fetal Monitoring Market Size, Status and Forecast 2021-2027
QYR2104Z3237 2021年4月 91Pages
QYResearch社発行の本調査資料では、侵襲性胎児モニタリングのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（超音波・超音波検査、電子胎児モニタリング（EFM）、胎児電極、胎児ドップラー、子宮収縮モニター、その他）、用途別市場規模（分娩前胎...

世界の出生前、胎児＆新生児用機器市場規模・現状・予測（2021年-2027年）

Global Prenatal, Fetal and Neonatal Equipment Market Size, Status and Forecast 2021-2027
QYR2104Z4776 2021年4月 126Pages
QYResearch社発行の本調査資料では、出生前、胎児＆新生児用機器のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（出生前＆胎児用機器、超音波＆超音波検査装置、胎児ドップラー、胎児磁気共鳴画像法、胎児モニター、新生児用機器、乳児用加温器＆保育...

世界の出生前、胎児＆新生児用機器市場規模・現状・予測（2021年-2027年）

世界の無細胞DNA（cfDNA）検査市場規模・現状・予測（2021年-2027年） Cell-Free DNA are fragments of DNA which circulate in the blood fluid and can be utilized as valuable biomarkers. It is a new technology in which small quantity of liquid sample (saliva, urine, or blood) from the patient is collected to examine the freely flowing DNA. Cell-Free DNA (cfDNA) is a noni…
世界の無細胞DNA（cf-DNA）検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cell-Free DNA (cf-DNA) Testing Market The global Cell-Free DNA (cf-DNA) Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data int…
世界の宿主細胞汚染物質試験市場規模・現状・予測（2021年-2027年） Host cell proteins essentially refers to the heterogeneous group of proteins that are derived from host cells such as yeast, E-coli, and mammal, among others. They differ largely form each other in terms of properties, isoelectric point, and molecular mass. Identification and quantification of host …
世界のラベルフリー検出（LFD）市場規模・現状・予測（2021年-2027年） LFD technology is used in the process of drug discovery. The main use of LFD technology is kinetics and analysis during drug discovery. LFD technology is widely used for end-point screening and specificity testing. Some of the benefits of LFD technology include faster turnaround time, real-time kine…
世界の菌血症検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Bloodstream Infection Testing Market The global Bloodstream Infection Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…